Burden and economic cost of group A streptococcal pharyngitis

Pediatrics

Volumn 121, Issue 2, 2008, Pages 229-234

  Pfoh, Elizabeth ^a   Wessels, Michael R ^b   Goldmann, Donald ^b   Lee, Grace M ^a,b  

^a HARVARD MEDICAL SCHOOL   (United States)

^b BOSTON CHILDREN S HOSPITAL   (United States)

Author keywords

Economic burden; Group A streptococcus; Pharyngitis; Vaccine

Indexed keywords

AMOXICILLIN; AZITHROMYCIN; CEFALEXIN; PENICILLIN G;

ABDOMINAL PAIN; ARTICLE; CHILD; CLINICAL FEATURE; CONTROLLED STUDY; DATA ANALYSIS; FEMALE; FEVER; HEALTH CARE COST; HUMAN; MALE; MORBIDITY; PHARYNGITIS; PRIORITY JOURNAL; SORE THROAT; STREPTOCOCCUS INFECTION; SYMPTOMATOLOGY; VACCINATION;

ABSENTEEISM; CHILD; COST OF ILLNESS; HEALTH CARE COSTS; HEALTH SERVICES; HUMANS; PHARYNGITIS; STREPTOCOCCAL INFECTIONS; STREPTOCOCCUS PYOGENES;

EID: 38849133018     PISSN: 00314005     EISSN: 02105721     Source Type: Journal    
DOI: 10.1542/peds.2007-0484     Document Type: Article

References (35)

1. Linder JA, Bates DW, Lee GM, Finkelstein JA. Antibiotic treatment of children with sore throat. JAMA. 2005;294(18):2315-2322
2. Bisno AL. Acute pharyngitis: etiology and diagnosis. Pediatrics. 1996;97(6):949-954
3. O'Brien KL, Beall B, Barrett NL, et al. Epidemiology of invasive group A streptococcus disease in the United States, 1995-1999. Clin Infect Dis. 2002;35(3):268-276
4. Hoge CW, Schwartz B, Talkington DF, Breiman RF, MacNeill EM, Englender SJ. The changing epidemiology of invasive group A streptococcal infections and the emergence of streptococcal toxic shock-like syndrome: a retrospective population-based study. JAMA. 1993;269(3):384-389
5. Haukness HA, Tanz RR, Thomson RB Jr, et al. The heterogeneity of endemic community pediatric group A streptococcal pharyngeal isolates and their relationship to invasive isolates. J Infect Dis. 2002;185(7):915-920
6. Muotiala A, Seppala H, Huovinen P, Vuopio-Varkila J. Molecular comparison of group A streptococci of T1M1 serotype from invasive and noninvasive infections in Finland. J Infect Dis. 1997;175(2):392-399
7. Cockerill FR III, MacDonald KL, Thompson RL, et al. An outbreak of invasive group A streptococcal disease associated with high carriage rates of the invasive clone among school-aged children. JAMA. 1997;277(1):38-43
8. McNeil SA, Halperin SA, Langley JM, et al. Safety and immunogenicity of 26-valent group A streptococcus vaccine in healthy adult volunteers. Clin Infect Dis. 2005;41(8):1114-1122
9. Haber M, Barskey A, Baughman W, et al. Herd immunity and pneumococcal conjugate vaccine: a quantitative model. Vaccine. 2007;25(29):5390-5398
10. Kotloff KL, Fattom A, Basham L, et al. Safety and immunogenicity of a recombinant multivalent group A streptococcal vaccine in healthy adults: phase 1 trial. JAMA. 2004;292(6):709-715
11. Lee GM, Lett S, Schauer S, et al. Societal costs and morbidity of pertussis in adolescents and adults. Clin Infect Dis. 2004;39(11):1572-1580
12. US Department of Health and Human Services. Medicare Program: Revisions to Payment Policies Under the Physician Fee Schedule for Calendar Year 2006 and Certain Provisions Related to the Competitive Acquisition Program of Outpatient Drugs and Biologicals Under Part B: Final Rule. Washington, DC: US Department of Health and Human Services; 2005. Report 42, CFR part 405:70458
13. American Academy of Pediatrics. Massachusetts Medicaid Reimbursement AAP 2004/05 Report. Elk Grove Village, IL: American Academy of Pediatrics; 2005. Available at: www.aap.org/research/medreimpdf0405/ma.pdf. Accessed March 15, 2006
14. Fleming T, ed. 2005 Drug Topics Red Book. Montvale, NJ: Thomson Medical Economics; 2005
15. Gold MR, Siegel JE, Russell LB, Weinstein MC, eds. Cost-Effectiveness in Health and Medicine. New York, NY: Oxford University Press; 1996
16. US Census Bureau. Annual Demographic Survey: March Supplement PINC-01 Selected money characteristics or people 15 years and over by total money income in 2004, work experience in 2004, race, Hispanic origin, and sex. [Female]. Washington, DC: US Census Bureau; 2005. Available at: http://pubdb3.census.gov/ macro/032005/perinc/new01_046.html. Accessed March 15, 2006
17. US Census Bureau. Annual Demographic Survey: March Supplement PINC-01 Selected money characteristics or people 15 years and over by total money income in 2004, work experience in 2004, race, Hispanic origin, and sex. [Male]. Washington, DC: US Census Bureau; 2005. Available at: http://pubdb3.census.gov/ macro/032005/perinc/new01_037.html. Accessed March 15, 2006
18. US House of Representatives, Committee on Ways and Means. Section 9, child care, Table 9-19. In: Green Book 2003. Washington, DC: US House of Representatives, Committee on Ways and Means; 2003. Available at: http://waysandmeans.house. gov/media/pdf/greenbook2003/Section9.pdf. Accessed July 9, 2007
19. Bureau of Labor Statistics. Consumer Price Index for Food and Energy: Boston-Brockton-Nashua, MA-NH-ME-CT. Washington, DC: Bureau of Labor Statistics; 2005. USDL-06-008
20. Energy Information Administration. Annual Energy Outlook 2006: With Projections to 2030. Washington, DC: Energy Information Administration; 2006. Available at: www.scag.ca.gov/rcp/pdf/publications/ 1_2006AnnualEnergyOutlook.pdf. Accessed March 15, 2006
21. Internal Revenue Service. IRS announces 2006 standard mileage rates. Available at: www.irs.gov/newsroom/article/0,id=151226,0.html. Accessed March 15, 2006
22. National Aeronautics and Space Administration. Gross domestic product deflator inflation calculator. Available at: www1.jsc.nasa.gov/bu2/inflateGDP. html. Accessed March 2, 2006
23. Widdowson M, Meltzer MI, Zhang X, Bresee JS, Parashar UD, Glass RI. Cost-effectiveness and potential impact of rotavirus vaccination in the United States. Pediatrics. 2007;119(4):684-697
24. Lieu TA, Cochi SL, Black SB, et al. Cost-effectiveness of a routine varicella vaccination program for US children. JAMA. 1994;271(5):375-381
25. Capra AM, Lieu TA, Black SB, Shinefield HR, Martin KE, Klein JO. Costs of otitis media in a managed care population. Pediatr Infect Dis J. 2000;19(4):354-355
26. Fendrick AM, Monto AS, Nightengale B, Sarnes M. The economic burden of non-influenza-related viral respiratory tract infection in the United States. Arch Intern Med. 2003;163(4):487-494
27. Schoen C, Davis K, How SK, Schoenbaum SC. US health system performance: a national scorecard. Health Aff (Millwood). 2006;25(6):w457-w475
28. Dingle JH, Badger GF, Jordan WS. Streptococcal infection. In: Dingle JH, Badger GF, Jordan WS, eds. Illness in the Home. Cleveland, OH: Western Reserve University; 1964:97-117
29. Martin JM, Green M, Barbadora KA, Wald ER. Erythromycin-resistant group A streptococci in schoolchildren in Pittsburgh. N Engl J Med. 2002;346(16):1200-1206
30. Cohen R, Levy C, de La Rocque F, et al. Impact of pneumococcal conjugate vaccine and of reduction of antibiotic use on nasopharyngeal carriage of nonsusceptible pneumococci in children with acute otitis media. Pediatr Infect Dis J. 2006;25(11):1001-1007
31. O'Brien KL, Dagan R. The potential indirect effect of conjugate pneumococcal vaccines. Vaccine. 2003;21(17-18):1815-1825
32. Centers for Disease Control and Prevention. Direct and indirect effects of routine vaccination of children with 7-valent pneumococcal conjugate vaccine on incidence of invasive pneumococcal disease: United States, 1998-2003. MMWR Morb Mortal Wkly Rep. 2005;54(36):893-897
33. Tan TQ. Pneumococcal conjugate vaccines: implications for community antibiotic prescribing. Curr Opin Microbiol. 2000;3(5):502-507
34. Seppälä H, Klaukka T, Vuopio-Varkila J, et al. The effect of changes in the consumption of macrolide antibiotics on erythromycin resistance in group A streptococci in Finland: Finnish Study Group for Antimicrobial Resistance. N Engl J Med. 1997;337(7):441-446
35. Albrich WC, Monnet DL, Harbarth S. Antibiotic selection pressure and resistance in Streptococcus pneumoniae and Streptococcus pyogenes. Emerg Infect Dis. 2004;10(3):514-517